NewGenIvf Group Limited (Class A) (NIVF) — RQD Stock Rating Cockpit

Per the Roarable RQD rating, NIVF carries an RQD Score of 20, a letter grade of E, and the verdict label "Roarable Strong Sell — Forensic Risk / Avoid." Across the five pillars, the Fundamental Cash Engine scores 1/20 (ROIC -32.8%; FCF yield 0%), indicating the weakest element of the rating: the business is not currently generating a return on invested capital or free cash flow relative to its price. The Whale 13F Flow pillar scores 3/20 for institutional accumulation and options positioning, and Insider Conviction scores 5/20 for SEC Form 4 and Congressional PTR cluster flow, both signaling limited sponsorship from informed holders. Macro Regime Fit scores 7/20 with a Beta of 1.0 and sector sensitivity noted, offering little macro tailwind. The Forensic Balance Sheet pillar scores 4/20 (Altman Z 0.63; Piotroski F 3/9; Debt/Equity 0.5), which places the company in a distress-leaning zone on the forensic metrics provided. For a prospective investor evaluating the stock today, the rating points to weak cash generation, limited institutional and insider conviction, and balance-sheet stress as the central considerations; any upside case would have to rest on a turnaround that the supplied data does not evidence.

Per the market data, operating margin is -60%, gross margin is 0%, and net margin is 68%, with the net margin figure diverging sharply from the operating loss reported for FY 2025. ROIC is -32.8% and FCF yield is 0%. Per the Roarable RQD rating, the Altman Z-Score is 0.63 and the Piotroski F-Score is 3/9, with Debt/Equity at 0.5; the source data does not state a separate debt figure, and the supplied cash balances are small relative to the reported negative free cash flow. Not available in source data for EPS across the reported periods.

Per the news section, one item is listed: a Simply Wall St report titled "NewGenIvf Group (Nasdaq:NIVF) - Stock Analysis," published one hour before the data timestamp, flagged YELLOW with a MARKET WIRE impact label, covering market action, institutional positioning, and fundamental catalysts. The source does not disclose the report's specific findings. Per the Butterfly Supply-Chain Graph, the supply-chain value is NONE and no butterfly links or proprietary signals are recorded. Key watch items are the sharp negative free cash flow in FY 2025 against a thin cash balance, and the substantial gap between the 52-week low of $0.96 and high of $20908.8.

Per the Butterfly Supply-Chain Graph, the supply chain is recorded as NONE, with no upstream or downstream links and no sector-correlation signals provided. Not available in source data for upstream dependencies, downstream customers, or sector correlations. A prospective investor should monitor whether future filings identify concentrated dependencies, since the absence of mapped links means no second-order ripples can be evaluated from the supplied data.

• What revenue-generating activities underlie the reported $4.7M of FY 2025 revenue, and what drove the swing from a $9.9M net income to a -$10.7M operating loss?
• Why is the 52-week range so wide (from $0.96 to $20908.8), and does that reflect a corporate action, a data error, or extreme price volatility?
• What debt obligations exist, given the Debt field is N/A in every reported period while Debt/Equity is cited as 0.5?
• How is the company funding negative free cash flow of -$11.1M against cash of $0.8M, and is there a going-concern or financing disclosure?
• What were the findings of the Simply Wall St report, and do they change the institutional or insider picture?